5,000 Alzheimer's patients monitored for brain side effects of new drug
NCT ID NCT06322667
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 5,000 people with early Alzheimer's who are taking the drug lecanemab in regular medical practice. The goal is to see how often brain changes called ARIA occur and how doctors manage treatment when they do. Researchers will also look at infusion reactions. This is an observational study, not a test of whether the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Eisai trial site 1
RECRUITINGTokyo, Japan
-
Eisai trial site 2
RECRUITINGHiroshima, Japan
-
Eisai trial site 3
RECRUITINGKyoto, Japan